SK282278B6 - Spôsob oxidácie delta-5-steroidného alkénu - Google Patents

Spôsob oxidácie delta-5-steroidného alkénu Download PDF

Info

Publication number
SK282278B6
SK282278B6 SK1478-96A SK147896A SK282278B6 SK 282278 B6 SK282278 B6 SK 282278B6 SK 147896 A SK147896 A SK 147896A SK 282278 B6 SK282278 B6 SK 282278B6
Authority
SK
Slovakia
Prior art keywords
process according
group
tert
substituted
compound
Prior art date
Application number
SK1478-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK147896A3 (en
Inventor
Ross A. Miller
Andrew S. Thompson
Raman K. Bakshi
Edward G. Corley
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of SK147896A3 publication Critical patent/SK147896A3/sk
Publication of SK282278B6 publication Critical patent/SK282278B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/46—Ruthenium, rhodium, osmium or iridium
    • B01J23/462—Ruthenium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/64—Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
    • B01J23/652—Chromium, molybdenum or tungsten
    • B01J23/6527—Tungsten
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1478-96A 1994-05-19 1995-05-15 Spôsob oxidácie delta-5-steroidného alkénu SK282278B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24593594A 1994-05-19 1994-05-19
PCT/US1995/006004 WO1995032215A1 (fr) 1994-05-19 1995-05-15 Oxydation de steroides possedant des groupes allyliques

Publications (2)

Publication Number Publication Date
SK147896A3 SK147896A3 (en) 1997-08-06
SK282278B6 true SK282278B6 (sk) 2002-01-07

Family

ID=22928693

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1478-96A SK282278B6 (sk) 1994-05-19 1995-05-15 Spôsob oxidácie delta-5-steroidného alkénu

Country Status (23)

Country Link
US (1) US6369247B1 (fr)
EP (1) EP0759929B1 (fr)
JP (1) JPH10500682A (fr)
KR (1) KR970703359A (fr)
CN (1) CN1152316A (fr)
AT (1) ATE195741T1 (fr)
AU (1) AU688513B2 (fr)
BR (1) BR9507663A (fr)
CA (1) CA2190500A1 (fr)
CZ (1) CZ338896A3 (fr)
DE (1) DE69518515T2 (fr)
DK (1) DK0759929T3 (fr)
ES (1) ES2149365T3 (fr)
FI (1) FI964610A (fr)
GR (1) GR3034201T3 (fr)
HK (1) HK1009274A1 (fr)
HU (1) HU223613B1 (fr)
NZ (1) NZ287230A (fr)
PT (1) PT759929E (fr)
RO (1) RO116550B1 (fr)
RU (1) RU2149875C1 (fr)
SK (1) SK282278B6 (fr)
WO (1) WO1995032215A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69615046T2 (de) * 1995-10-23 2002-06-27 Merck & Co Inc 17-alkyl-7-substituierte-4-aza-steroidderivate
US5763361A (en) * 1995-10-23 1998-06-09 Merck & Co., Inc. 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors
US5872126A (en) * 1996-09-06 1999-02-16 Merck & Co., Inc. Methods and compositions for treating preterm labor
US6686486B1 (en) 1997-05-07 2004-02-03 Padma Marwah Process for effecting allylic oxidation
US5869709A (en) * 1997-05-07 1999-02-09 Humanetics Corporation Process for effecting allylic oxidation
US6252119B1 (en) * 1997-07-28 2001-06-26 Salvador Jorge Antonio Riberiro Copper-catalysed allylic oxidation using alkyl hydroperoxide
US7012069B2 (en) * 2001-05-03 2006-03-14 Arch Development Corporation Liver X receptor agonists
US6187925B1 (en) 1997-12-23 2001-02-13 Merck & Co., Inc. Intermediates and process for the synthesis of azasteroids
AU3088799A (en) 1998-03-18 1999-10-11 Humanetics Corporation Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagents
EP1189922A4 (fr) 1999-04-30 2002-08-14 Arch Dev Corp Derives steroides
GB0020286D0 (en) * 2000-08-18 2000-10-04 Univ York Cobalt catalysed allylic oxidation of unsaturated steroids using alkyl hydroperoxide
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
AU2003228485A1 (en) * 2002-04-12 2003-10-27 The University Of Chicago Farnesoid x-activated receptor agonists
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
CA2600762C (fr) * 2005-03-10 2011-05-31 Jr Chem, Llc Compositions de peroxyde organique stables
JP2008533037A (ja) * 2005-03-10 2008-08-21 ジェイアール ケム エルエルシー 過酸化ベンゾイル組成物およびその使用方法
WO2007002880A2 (fr) * 2005-06-29 2007-01-04 Jr Chem, Llc Methode pour application amelioree de medicament
US20070001145A1 (en) * 2005-06-29 2007-01-04 Faryniarz Joseph R Stable organic peroxide compositions
US7556820B2 (en) 2005-06-29 2009-07-07 Jr Chem, Llc Stable organic peroxide compositions
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
CN101619089B (zh) * 2009-07-28 2011-07-20 陈大刚 抗肿瘤药物cl168、其合成方法及应用
US8829213B2 (en) * 2009-07-29 2014-09-09 The University Of Chicago Liver X receptor agonists
KR101554402B1 (ko) * 2011-01-31 2015-09-18 아사히 가세이 케미칼즈 가부시키가이샤 혼합액 제조 장치 및 혼합액 조제 방법
WO2013101719A2 (fr) 2011-12-27 2013-07-04 Northeast Ohio Medical University Composés et analogues d'amooranine et procédés d'utilisation associés
JP2016519085A (ja) * 2013-03-15 2016-06-30 ザ フロリダ ステイト ユニバーシティー リサーチ ファウンデーション， インコーポレイテッドＴｈｅ Ｆｌｏｒｉｄａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ， Ｉｎｃｏｒｐｏｒａｔｅｄ ｅｎｔ−プロゲステロンおよびその中間体の合成
CN103788163B (zh) * 2014-01-27 2015-11-18 浙江大学 7-酮基甾类化合物的制备方法
JP7048976B2 (ja) 2015-11-23 2022-04-06 レトロトップ、 インコーポレイテッド １，４－ジエン系の部位特異的同位体標識
CN106008423B (zh) * 2016-06-24 2018-02-02 云南民族大学 一种苯丙素类化合物及其制备方法和应用
EP4107163A4 (fr) 2020-02-21 2024-06-19 Retrotope, Inc. Procédés de modification isotopique d'acides gras polyinsaturés et leurs dérivés

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422443D0 (en) * 1984-09-05 1984-10-10 British Petroleum Co Plc Oxidation of hydrocarbons
DK173704B1 (da) 1985-04-17 2001-07-09 Hoffmann La Roche Fremgangsmåde til katalytisk oxidation af allyliske grupper
SK137994A3 (en) * 1992-05-20 1995-04-12 Merck & Co Inc 7-beta-substituted-4-aza-5-alpha-cholestan-ons their using for production of pharmaceutical agent and pharmaceutical agent containing them
IL111467A0 (en) 1993-11-12 1994-12-29 Merck & Co Inc Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors

Also Published As

Publication number Publication date
AU688513B2 (en) 1998-03-12
ATE195741T1 (de) 2000-09-15
FI964610A0 (fi) 1996-11-18
CA2190500A1 (fr) 1995-11-30
DK0759929T3 (da) 2000-11-13
EP0759929A4 (fr) 1998-09-30
EP0759929B1 (fr) 2000-08-23
RO116550B1 (ro) 2001-03-30
HU223613B1 (hu) 2004-10-28
BR9507663A (pt) 1997-10-07
US6369247B1 (en) 2002-04-09
SK147896A3 (en) 1997-08-06
AU2588595A (en) 1995-12-18
FI964610A (fi) 1996-11-18
ES2149365T3 (es) 2000-11-01
PT759929E (pt) 2001-01-31
HU9603187D0 (en) 1997-01-28
HK1009274A1 (en) 1999-05-28
DE69518515D1 (de) 2000-09-28
CZ338896A3 (en) 1997-07-16
GR3034201T3 (en) 2000-11-30
WO1995032215A1 (fr) 1995-11-30
RU2149875C1 (ru) 2000-05-27
CN1152316A (zh) 1997-06-18
KR970703359A (ko) 1997-07-03
DE69518515T2 (de) 2001-04-19
NZ287230A (en) 1997-07-27
EP0759929A1 (fr) 1997-03-05
HUT75778A (en) 1997-05-28
JPH10500682A (ja) 1998-01-20

Similar Documents

Publication Publication Date Title
SK282278B6 (sk) Spôsob oxidácie delta-5-steroidného alkénu
US5237064A (en) Process for producing 7β-substituted-aza-5αandrostan-3-ones
EP2513132B1 (fr) Procédés pour la purification de l'acide désoxycholique
JPH0651718B2 (ja) アザステロイドに１，２二重結合を導入する方法
JPH0725791B2 (ja) 脱水素方法及び中間体
SK137994A3 (en) 7-beta-substituted-4-aza-5-alpha-cholestan-ons their using for production of pharmaceutical agent and pharmaceutical agent containing them
US5696266A (en) Process for the stereoselective reduction of steroid enelactams
US5219879A (en) Heterocyclic steroid compounds
CA2098146C (fr) Nouveau procede de preparation de composes steroides 20-ceto 21alpha-hydroxy et intermediaires
EP0528485A1 (fr) 17 beta-acyl-3-androsta-3,5-diènes comme inhibiteurs de la testostérone 5 alpha-réductase
EP1558627B1 (fr) Reduction stereospecifique de sapon-3-ones
JPS60252494A (ja) エストロゲン合成阻害剤
MXPA96005718A (en) Oxidation of steroids that have alili groups
US2741626A (en) Hydroxylated steroids
US3906096A (en) Novel 11{62 -alkoxy steroids
US2884419A (en) Chemical compounds and processes for preparing the same
US3535350A (en) Process for the preparation of 13-alkyl gona-1,3,5(10),8,14-pentaen - 17 - ones from the corresponding 17-ols
US2688615A (en) 3-acyloxy-5, 7-9(11)-etiocholatrienic acid adducts
CH508610A (fr) Procédé de préparation de 7ä-méthyl gona-4,9-diènes substitués
SK13252001A3 (sk) Spôsob prípravy esterov kyseliny 4,4-dimetyl-3beta- hydroxypregna-8,14-dién-21-karboxylovej, ich použitie a medziprodukty získané pri tejto príprave
JPH02207096A (ja) ２１―アシルオキシ―２０―ケト―△↑１↑６―ステロイドの製造法